Tag: Amgen

Quantinuum closes $300m equity fundraise, valued at $5bn pre-money

businessnewstoday- January 18, 2024

Quantinuum, a global leader in integrated quantum computing, has announced the closing of a substantial $300 million equity fundraise. This financial milestone, achieved at a ... Read More

Glenmark Pharmaceuticals secures FDA approval for generic version of Otezla Tablets

businessnewstoday- October 17, 2023

Glenmark Pharmaceuticals Ltd. has successfully secured the final approval from the United States Food & Drug Administration (U.S. FDA) for its Apremilast Tablets in 10 ... Read More

Amgen to acquire Irish biopharma company Horizon Therapeutics for $28bn

Raghuram Kadari- December 13, 2022

Amgen through its wholly-owned subsidiary Pillartree has agreed to acquire Ireland-based biopharmaceutical firm Horizon Therapeutics for an enterprise value of around $28.3bn. The US biotechnology ... Read More

Amgen to acquire American biopharma company ChemoCentryx for $3.7bn

pallavi123- August 4, 2022

Amgen has agreed to acquire ChemoCentryx, a biopharma company engaged in developing medications for inflammatory and autoimmune diseases and cancer, in an all-cash deal worth ... Read More

Liberty Mutual wraps up $515m acquisition of Malaysian insurer AmGeneral

businessnewstoday- July 29, 2022

Liberty Mutual Insurance has wrapped up the previously announced MYR 2.29 billion ($515 million) acquisition of AmGeneral Insurance Berhad, a Malaysian insurer, having secured regulatory ... Read More

Amgen, Generate Biomedicines sign $1.9bn worth research collaboration deal

pallavi123- January 8, 2022

Amgen has signed a research collaboration deal worth up to $1.9 billion with Cambridge-based Generate Biomedicines for the discovery and development of protein therapeutics for ... Read More

LUMAKRAS FDA approval : Amgen bags approval in KRAS G12C-mutated NSCLC

pallavi123- May 29, 2021

LUMAKRAS FDA approval : Amgen has bagged accelerated approval from the US Food and Drug Administration (FDA) for LUMAKRAS (sotorasib) for the treatment of a ... Read More

Amgen to acquire Rodeo Therapeutics in $721m worth deal

pallavi123- March 31, 2021

Amgen has agreed to acquire Rodeo Therapeutics, a Seattle-based biopharma company, in a deal worth up to $721 million. Rodeo Therapeutics is engaged in developing ... Read More

Amgen to acquire Five Prime Therapeutics for gastric cancer candidate bemarituzumab

pallavi123- March 4, 2021

Amgen acquisition of Five Prime Therapeutics : Amgen has agreed to acquire Five Prime Therapeutics, a clinical-stage biotech company, for about $1.9 billion, to add ... Read More

Amgen gets breakthrough therapy status for sotorasib in China

pharmanewsdaily- January 31, 2021

Amgen said that sotorasib, an investigational KRASG12C inhibitor, has been given breakthrough therapy designation (BTD) from the Center for Drug Evaluation (CDE) of the National ... Read More